Pacific Edge shares soar on milestone US regulation approval

Pacific Edge shares more than doubled in value on confirmation of acceptance under a key US medical regulation for its Cxbladder cancer test.The shares jumped as high as 68 cents from 27 cents yesterday, and closed the day at 55...

More Headlines

Follow worldbiztoday on Twitter

US Stocks